Navigation Links
PM Versus MIM: TM&S President to Explain Niche Metal Fabrication Methods During IHS GlobalSpec Event
Date:9/24/2013

Minneapolis, Minnesota (PRWEB) September 24, 2013

Derek Rasmussen, President of TM&S, LLC, will present “Powder Metal Part Design Fundamentals,” a free Webinar taking place on October 23, 2013, at 12:30 P.M. EST, during IHS GlobalSpec’s Aerospace Technology online event.

The informational session will help engineering, sales, and other professionals involved in component design for manufacture (DFM) understand the characteristics and best uses for Press and Sinter (conventional powder metal, or PM) and Metal Injection Molding (MIM), respectively. Both are classified as powder metal technologies and are used in the medical device, computer, communications, automotive, firearms, defense, aerospace, and consumer electronics industries. But there are vast differences between them in terms of manufacturing processes and capabilities.

With 20 years’ experience in component design, mold design, part processing, and troubleshooting high-volume manufacturing processes to increase yields, Mr. Rasmussen is uniquely qualified to give attendees a fundamental comparison of PM and MIM manufacturing technologies. His Webinar will help participants improve their cost analysis and sourcing decisions, as well as enhance communication with suppliers.

TM&S, LLC, is a trusted resource for custom component designers and manufacturers. It exclusively represents four companies specializing in niche powder metal technologies: ecoMIM of Retsag, Hungary (Metal Injection Molding); element22 of Kiel, Germany (Titanium MIM); FMS Corporation of Minneapolis, Minnesota (Press and Sinter and Micro MIM); and Liquidmetal Technologies of Rancho Santa Margarita, California. Their complementary capabilities allow TM&S to provide the best solution for any component suited to powder metal technology, whether round parts, complex geometric profiles, micro parts with high tolerances, or low-cost Titanium parts.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11150788.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Lillys Investigational GLP-1 Receptor Agonist, Dulaglutide, Showed Superior Glycemic Control Versus Comparators in Patients with Type 2 Diabetes
2. TM&S Opens Office Dedicated to Powder Metal, Metal Injection Molding and Liquid Metal
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. Elsevier / MEDai Appoints Tom Zajac as New President
5. GenVec President and Chief Executive Officer Announces Retirement
6. Michael A. Marletta Takes Office as New President of Scripps Research Institute
7. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
8. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
9. Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase
10. Zyga Technology, Inc. Announces the Appointment of Jim Bullock as President and CEO
11. Cepheid Welcomes Senior Vice President of Human Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... NC (PRWEB) , ... June 24, 2016 , ... Researchers ... the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are ... to read it now. , Diagnostic biomarkers are signposts in the blood, lung ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):